RT Journal Article
SR Electronic
T1 Effects of adiposity on the human plasma proteome: Observational and Mendelian randomization estimates
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.01.20119081
DO 10.1101/2020.06.01.20119081
A1 Goudswaard, Lucy J.
A1 Bell, Joshua A.
A1 Hughes, David A.
A1 Corbin, Laura J.
A1 Walter, Klaudia
A1 Smith, George Davey
A1 Soranzo, Nicole
A1 Danesh, John
A1 Di Angelantonio, Emanuele
A1 Ouwehand, Willem H.
A1 Watkins, Nicholas A.
A1 Roberts, David J.
A1 Butterworth, Adam S.
A1 Hers, Ingeborg
A1 Timpson, Nicholas J.
YR 2020
UL http://medrxiv.org/content/early/2020/06/03/2020.06.01.20119081.abstract
AB Background Variation in adiposity is associated with cardiometabolic disease outcomes, but the mechanisms leading from this exposure to disease are unclear. This study aimed to estimate effects of adiposity, proxied by body mass index (BMI), on an extensive set of circulating proteins using both observational and genetically informed analyses.Methods and findings We used proteomic data from up to 2,737 healthy participants from the INTERVAL study of UK blood donors. Associations between self-reported BMI and 3,622 unique plasma proteins measured by the SomaLogic platform were explored using linear regression. These were complemented by Mendelian randomization (MR) analyses using a genetic risk score (GRS) comprised of 654 BMI-associated polymorphisms from a recent genome-wide association study (GWAS) of adult BMI. Observationally, BMI showed associations with 1,576 protein traits (Bonferroni corrected P < 1.4 × 10−5), with strong associations with leptin, fatty acid-binding protein 4 (FABP4) and sex hormone binding globulin (SHBG). The GRS for BMI was positively associated with self-reported BMI to the extent expected given its known genetic association (R2 = 0.028) and there was a lack of strong association between this GRS and measured confounding factors. MR analyses provided further evidence for a causal relationship between BMI and a range of measured proteins (eight in this analysis achieved P < 1.4×10−5) including a strong relationship with leptin levels (0.63 standard deviation (SD) per SD BMI, 95% CI 0.48 to 0.79, P = 1.6×10−15), FABP4 (0.64 SD per SD BMI, 95% CI 0.46 to 0.83, P = 6.7×10−12) and SHBG abundance (−0.45 SD per SD BMI, 95% CI –0.65 to –0.25, P = 1.4×10−5). There was strong agreement in the direction and magnitude of observational and MR estimates (R2 = 0.33) and evidence that proteins most strongly altered by BMI were enriched for genes involved in cardiovascular disease (1.14 fold enrichment, P = 1.3 × 10−4). Limitations of this particular set of analyses include a modest sample size and a derivation of measured BMI from self-reported height and weight.Conclusions This study provides evidence for a broad impact of adiposity on the human proteome. Proteins most strongly altered by BMI include those which are involved in regulating appetite, sex hormones, and inflammation; such proteins are also enriched for genes related to cardiovascular disease. These results help to focus attention onto new potential targets for obesity-related disease prevention.Competing Interest StatementJohn Danesh sits on the International Cardiovascular and Metabolic Advisory Board for Novartis (since 2010); the Steering Committee of UK Biobank (since 2011); the MRC International Advisory Group (ING) member, London (since 2013); the MRC High Throughput Science Omics Panel Member, London (since 2013); the Scientific Advisory Committee for Sanofi (since 2013); the International Cardiovascular and Metabolism Research and Development Portfolio Committee for Novartis; and the Astra Zeneca Genomics Advisory Board (2018).Funding StatementFunding: This publication is the work of the authors who are guarantors for its contents. LJG is funded by the University of Bristol alumni on the 4-year BHF Integrative Cardiovascular Science PhD programme. JAB is supported by the Elizabeth Blackwell Institute for Health Research, University of Bristol and the Wellcome Trust Institutional Strategic Support Fund (204813/Z/16/Z). DAH and LJC are funded by the Wellcome Trust (202802/Z/16/Z). KW is supported by the Wellcome Trust. GDS works in the Medical Research Council Integrative Epidemiology Unit at the University of Bristol, which is supported by the Medical Research Council (MC_UU_00011/1). NS is supported by the Wellcome Trust, British Heart Foundation and NIHR funding to the Cambridge Bioresource. JD is funded by the National Institute for Health Research (Senior Investigator Award). IH is supported by the EPSRC Prostanoid programme (EP/M012530/1) and BHF (PG/16/3/31833). NJT is a Wellcome Trust Investigator (202802/Z/16/Z), is the PI of the Avon Longitudinal Study of Parents and Children (MRC & WT 102215/2/13/2), is supported by the University of Bristol NIHR Biomedical Research Centre (BRC-1215-20011), the MRC Integrative Epidemiology Unit (MC_UU_12013/3) and works within the CRUK Integrative Cancer Epidemiology Programme (C18281/A19169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by Cambridge (East) Research Ethics Committee. Access to the data was granted by the Data Access Committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData cannot be publicly shared due to sensitive content. General enquiries can be sent to the INTERVAL team https://www.intervalstudy.org.uk/more-information/